Semaglutide FAQ
Semaglutide is a long-acting analog of a naturally occurring hormone in the body (GLP-1) and was FDA approved in 2021 for the treatment of obesity and well as readily prescribed for the treatment of diabetes since 2017.
*Individual patient results may vary.